世界のリキッドバイオプシー市場予測2020-2028

◆英語タイトル:GLOBAL LIQUID BIOPSY MARKET FORECAST 2020-2028
◆商品コード:INK20AG048
◆発行会社(リサーチ会社):Inkwood Research
◆発行日:2020年7月
◆ページ数:248
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥262,500見積依頼/購入/質問フォーム
Multi LicenseUSD3,000 ⇒換算¥315,000見積依頼/購入/質問フォーム
Enterprisewide PriceUSD4,500 ⇒換算¥472,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はInkwood Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Inkwood Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査レポートでは、リキッドバイオプシーの世界市場について調査を行い、調査手法、エグゼクティブサマリー、市場動向、主要分析、治療別(肺がん、乳がん、前立腺がん、結腸直腸がん、黒色腫がん)分析、臨床応用別分析、バイオマーカー種類別分析、分析プラットフォーム別分析、分析目的別分析、製品別分析、エンドユーザー別分析、地域別分析、企業情報などをまとめております。
・調査手法
・エグゼクティブサマリー
・市場動向
・主要分析
・リキッドバイオプシーの世界市場規模:治療別(肺がん、乳がん、前立腺がん、結腸直腸がん、黒色腫がん)
・リキッドバイオプシーの世界市場規模:臨床応用別
・リキッドバイオプシーの世界市場規模:バイオマーカー種類別
・リキッドバイオプシーの世界市場規模:分析プラットフォーム別
・リキッドバイオプシーの世界市場規模:分析目的別
・リキッドバイオプシーの世界市場規模:製品別
・リキッドバイオプシーの世界市場規模:エンドユーザー別
・リキッドバイオプシーの世界市場規模:地域別
・企業情報
【レポートの概要】

KEY FINDINGS
The global liquid bioscopy market is predicted to register a CAGR of 20.50% during the forecast period of 2020 to 2028. The primary factors propelling the market growth are growth in precision medicine, rising government initiatives, the growing pervasiveness of cancer in the older population, increasing potential of liquid biopsies, and technological advancements.

MARKET INSIGHTS
Due to rapid changes in consumer demands, diagnostic testing has been shifted from hospitals and commercial laboratories, to locations closer to the patient’s home. This has resulted in minimizing the overall cost of testing. Most healthcare services in urban areas are delivered at home with a reduced focus on rural areas. Moreover, developing countries also have a high percentage of people residing in rural areas, with very few diagnostic centers and low accessibility. Thus, fatalities due to cancer are very high in rural environments. The increasing death toll can be attributed to a lack of awareness of the disease, leading to ignorance of diagnosis and treatment. Hence, it is anticipated that improved diagnostic tools, faster response times, easy availability of biopsy solutions at an inexpensive rate, and high amounts of research grants would lead to establishing numerous diagnostic centers, especially in rural areas and developing countries in the region. Consequently, the growing number of diagnostic centers are projected to offer a lucrative opportunity for biopsy solution providers and augment market growth.

REGIONAL INSIGHTS
Countries across the Asia Pacific, North America, Europe, and the rest of the world are analyzed to assess global liquid biopsy market growth. According to Inkwood Research, North America is estimated to garner the largest revenue share by the end of the forecast period. As a result of the increasing number of cancer cases, the demand for liquid biopsy in North America is projected to rise. Canada and the United States have superior biopsy technologies that specialize in detecting diseases at the early stages, thus reducing the countries’ mortality rates.

COMPETITIVE INSIGHTS
As the global liquid biopsy market continues to emerge, regular and rapid developments are being witnessed. There are very few obstructions to innovations entering the market, resulting in medium to high levels of industry rivalry. Some of the established companies in the market include Cook Medical Inc, F Hoffmann-La Roche, Qiagen NV, Planmeca OY, Boston Scientific Corporation, Bio-Rad Laboratories, etc.

Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation cater to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

【レポートの目次】

TABLE OF CONTENTS
1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. SCOPE OF STUDY
1.3. METHODOLOGY
1.4. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW
3. MARKET DYNAMICS
3.1. MARKET DEFINITION
3.2. KEY DRIVERS
3.2.1. RISING GOVERNMENT INITIATIVES
3.2.2. GROWING PERVASIVENESS OF CANCER CASES IN OLDER POPULACE
3.2.3. GROWING NUMBER OF DIAGNOSTIC CENTERS
3.2.4. GROWTH OF PRECISION MEDICINE
3.2.5. EMERGENCE OF TISSUE/TUMOR-AGNOSTIC DRUGS
3.2.6. RISING POTENTIAL OF THE LIQUID BIOPSY
3.2.7. TECHNOLOGICAL ADVANCEMENT
3.3. KEY RESTRAINTS
3.3.1. LACK OF CONSENSUS ON STANDARD OPERATING PROCEDURES (SOPS)
3.3.2. POOR COMPENSATION STRUCTURES
3.3.3. HIGH COST OF THE TEST
3.3.4. LACK OF REIMBURSEMENT
3.3.5. LACK OF SKILLED PROFESSIONALS
4. KEY ANALYTICS
4.1. PORTER’S FIVE FORCE ANALYSIS
4.1.1. THREAT OF NEW ENTRY
4.1.2. THREAT OF SUBSTITUTION
4.1.3. BUYER’S POWER
4.1.4. SUPPLIER’S POWER
4.1.5. COMPETITIVE RIVALRY
4.2. KEY LIQUID BIOPSY INITIATIVES
4.3. REGULATORY FRAMEWORK
4.4. OPPORTUNITY MATRIX
4.5. VENDOR LANDSCAPE
4.6. KEY INVESTMENT INSIGHTS
5. MARKET BY THERAPEUTIC APPLICATION
5.1. LUNG CANCER
5.2. BREAST CANCER
5.3. PROSTATE CANCER
5.4. COLORECTAL CANCER
5.5. MELANOMA CANCER
5.6. OTHER TYPES OF CANCER
5.7. NON-ONCOLOGY APPLICATION
6. MARKET BY CLINICAL APPLICATION
6.1. TREATMENT MONITORING
6.2. PROGNOSIS AND REOCCURRENCE MONITORING
6.3. TREATMENT SELECTION
6.4. DIAGNOSIS AND SCREENING
7. MARKET BY BIOMARKER TYPE
7.1. NUCLEIC ACID
7.2. PROTEIN
7.3. EXTRACELLULAR VESICLES
7.4. CELLS
8. MARKET BY ANALYSIS PLATFORM
8.1. NGS
8.2. MICROARRAY
8.3. PCR
8.4. PROTEOMICS
8.5. OTHER ANALYSIS PLATFORMS
9. MARKET BY ANALYSIS PURPOSE
9.1. EARLY DETECTION/SCREENING
9.2. THERAPY GUIDANCE
9.3. MONITORING
9.4. DIAGNOSIS
10. MARKET BY PRODUCT
10.1. CIRCULATING TUMOR DNA (CTDNA)
10.2. CIRCULATING TUMOR CELLS (CTCS)
10.3. CELL-FREE DNA (CFDNA)
10.4. EXTRACELLULAR VESICLES AND OTHERS
11. MARKET BY END-USER
11.1. PHYSICIANS’ OFFICE LABORATORIES
11.2. HOSPITALS
11.3. CLINICAL DIAGNOSTIC LABORATORIES
12. GEOGRAPHICAL ANALYSIS
12.1. NORTH AMERICA
12.1.1. THE UNITED STATES
12.1.2. CANADA
12.2. EUROPE
12.2.1. THE UNITED KINGDOM
12.2.2. FRANCE
12.2.3. GERMANY
12.2.4. ITALY
12.2.5. RUSSIA
12.2.6. BELGIUM
12.2.7. POLAND
12.2.8. REST OF EUROPE
12.3. ASIA PACIFIC
12.3.1. JAPAN
12.3.2. CHINA
12.3.3. INDIA
12.3.4. SOUTH KOREA
12.3.5. AUSTRALIA & NEW ZEALAND
12.3.6. THAILAND
12.3.7. INDONESIA
12.3.8. VIETNAM
12.3.9. REST OF ASIA PACIFIC
12.4. REST OF WORLD
12.4.1. LATIN AMERICA
12.4.2. MIDDLE EAST & AFRICA
13. COMPANY PROFILES
13.1. BECTON DICKINSON AND COMPANY (BD)
13.2. F HOFFMANN-LA ROCHE
13.3. BIO-RAD LABORATORIES INC
13.4. B BRAUN MELSUNGEN AG
13.5. BOSTON SCIENTIFIC CORPORATION
13.6. QIAGEN NV
13.7. PLANMECA OY
13.8. COOK MEDICAL INC
13.9. AD-TECH MEDICAL INSTRUMENT CORP
13.10. AGILENT TECHNOLOGIES INC
13.11. ARGON MEDICAL DEVICES INC
13.12. CINTEC MEDICAL LTD
13.13. FISCHER MEDICAL TECHNOLOGIES LLC
13.14. IMS INTERNAZIONALE MEDICO SCIENTIFICA SRL

LIST OF TABLES
TABLE 1: MARKET SNAPSHOT - LIQUID BIOPSY
TABLE 2: GOVERNMENT INITIATIVES FOR CANCER AND LIQUID BIOPSY TESTING IN SOME COUNTRIES
TABLE 3: GLOBAL LIQUID BIOPSY MARKET, BY THERAPEUTIC APPLICATION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 4: GLOBAL LIQUID BIOPSY MARKET, BY THERAPEUTIC APPLICATION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 5: GLOBAL LIQUID BIOPSY MARKET, BY CLINICAL APPLICATION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 6: GLOBAL LIQUID BIOPSY MARKET, BY CLINICAL APPLICATION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 7: GLOBAL LIQUID BIOPSY MARKET, BY BIOMARKER TYPE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 8: GLOBAL LIQUID BIOPSY MARKET, BY BIOMARKER TYPE, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 9: GLOBAL LIQUID BIOPSY MARKET, BY ANALYSIS PLATFORM, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 10: GLOBAL LIQUID BIOPSY MARKET, BY ANALYSIS PLATFORM, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 11: NEXT-GENERATION SEQUENCING INSTRUMENT COMPANIES
TABLE 12: ADVANTAGES OF DROPLET DIGITAL PCR FOR SINGLE-CELL ANALYSIS
TABLE 13: GLOBAL LIQUID BIOPSY MARKET, BY ANALYSIS PURPOSE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 14: GLOBAL LIQUID BIOPSY MARKET, BY ANALYSIS PURPOSE, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 15: GLOBAL LIQUID BIOPSY MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 16: GLOBAL LIQUID BIOPSY MARKET, BY PRODUCT, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 17: GLOBAL LIQUID BIOPSY MARKET, BY END-USER, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 18: GLOBAL LIQUID BIOPSY MARKET, BY END-USER, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 19: GLOBAL LIQUID BIOPSY MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 20: GLOBAL LIQUID BIOPSY MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 21: NORTH AMERICA LIQUID BIOPSY MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 22: NORTH AMERICA LIQUID BIOPSY MARKET, BY COUNTRY, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 23: EUROPE LIQUID BIOPSY MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 24: EUROPE LIQUID BIOPSY MARKET, BY COUNTRY, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 25: ASIA PACIFIC LIQUID BIOPSY MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 26: ASIA PACIFIC LIQUID BIOPSY MARKET, BY COUNTRY, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 27: REST OF WORLD LIQUID BIOPSY MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 28: REST OF WORLD LIQUID BIOPSY MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)


【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[世界のリキッドバイオプシー市場予測2020-2028]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆